跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Docaten - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Docaten
Approved
STANDARD
Docaten
Phil. United Pharma Corporation
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8c7cd2d79d136164
Company
Phil. United Pharma Corporation
Type
Standard
Approval Details
Approval Id
8c7cd2d79d136164
Drug Approval Philippines Name
Docaten
Product Name
Docaten
Registration Number
DRP-14357
Brand Name
Docaten
Generic Name
Atenolol
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg
Manufacturer
Phil. United Pharma Corporation
Trader
Docteur's Choice Corporation
Issuance Date
24 August 2023
Expiry Date
24 August 2028
Pharmacologic Category
Beta Blocking Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8c7cd2d79d136164
Type
Standard
Back to Philippines FDA Approvals